Interferon Stimulated Exonuclease Gene 20kDa (ISG20) Peptide
ISG20
Reactivité: Humain
Hôte: Synthetic
BP, WB
-
- Antigène Tous les produits ISG20
- ISG20 (Interferon Stimulated Exonuclease Gene 20kDa (ISG20))
- Origine
- Humain
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Attributs du produit
- This is a synthetic peptide designed for use in combination with anti-ISG20 antibody (Catalog #: ARP40391_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Indications d'application
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Conseil sur la manipulation
- Avoid repeated freeze-thaw cycles.
- Stock
- -20 °C
- Stockage commentaire
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Antigène
- ISG20 (Interferon Stimulated Exonuclease Gene 20kDa (ISG20))
- Synonymes
- ISG20 Peptide, CD25 Peptide, HEM45 Peptide, 1600023I01Rik Peptide, 2010107M23Rik Peptide, 20kDa Peptide, DnaQL Peptide, interferon stimulated exonuclease gene 20 Peptide, interferon-stimulated protein Peptide, ISG20 Peptide, Isg20 Peptide
- Sujet
-
ISG20 belongs to the the exonuclease superfamily. It is exonuclease with specificity for single-stranded RNA and, to a lesser extent for DNA. It degrades RNA at a rate that is approximately 35-fold higher than its rate for single-stranded DNA. It is involved in the antiviral function of IFN against RNA viruses.
Alias Symbols: CD25, HEM45
Protein Size: 181 - Poids moléculaire
- 20 kDa
- ID gène
- 3669
- NCBI Accession
- NM_002201, NP_002192
- UniProt
- Q96AZ6
-
Vous êtes ici:
